Request Deal Involvement
Channel Therapeutics completed acquisition of Pelthos Therapeutics a subsidiary compny of Ligand, for a total of $50m..
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Raymond James
legal advisors
Sullivan & Worcester
pr advisors
Longacre Square Partners
pr advisors
LifeSci Partners
legal advisors
Latham & Watkins
legal advisors
Kelley Drye & Warren
or
Principals
target
PELTHOS THERAPEUTICS
bidder
CHANNEL THERAPEUTICS
vendor
LIGAND PHARMACEUTICALS INC
bidder
MURCHINSON
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite